Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants

Abstract Data on the immunogenicity and memory induction of pneumococcal conjugate vaccines in very preterm infants is limited. We vaccinated 69 full term and 68 preterm infants (median gestational age (GA) 30 weeks) with a 7-valent pneumococcal conjugate vaccine (PCV7) at 2/3/4 months of age, follo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2007-01, Vol.25 (2), p.264-271
Hauptverfasser: Ruggeberg, Jens U, Collins, Clare, Clarke, Paul, Johnson, Nik, Sinha, Ruchi, Everest, Neil, Chang, John, Stanford, Elaine, Balmer, Paul, Borrow, Ray, Martin, Sarah, Robinson, Michael J, Moxon, E Richard, Pollard, Andrew J, Heath, Paul T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 271
container_issue 2
container_start_page 264
container_title Vaccine
container_volume 25
creator Ruggeberg, Jens U
Collins, Clare
Clarke, Paul
Johnson, Nik
Sinha, Ruchi
Everest, Neil
Chang, John
Stanford, Elaine
Balmer, Paul
Borrow, Ray
Martin, Sarah
Robinson, Michael J
Moxon, E Richard
Pollard, Andrew J
Heath, Paul T
description Abstract Data on the immunogenicity and memory induction of pneumococcal conjugate vaccines in very preterm infants is limited. We vaccinated 69 full term and 68 preterm infants (median gestational age (GA) 30 weeks) with a 7-valent pneumococcal conjugate vaccine (PCV7) at 2/3/4 months of age, followed by a plain polysaccharide booster at 12 months of age. IgG-GMC (ELISA) was significantly lower in preterm infants to six vaccine serotypes (ST) at 2 months and 5 months of age, to five ST at 12 months of age and to three ST at 13 months of age. A significantly lower proportion of preterm infants achieved IgG levels ≥0.35 μg/ml to ST 4, 6B and 9V at 5 months and to ST 4, 6B, 18C, 19F and 23F at 12 months of age. Fold rises following the polysaccharide booster were comparable to those of term infants. At least 93% of both cohorts achieved IgG ≥0.35 μg/ml to all STs following booster vaccination. Pneumococcal conjugate vaccine at an accelerated schedule of 2/3/4 months of age is likely to provide protection against pneumococcal disease for preterm infants. Antibody concentrations wane over the first year of life in both preterm and term infants and booster vaccination is therefore likely to be important.
doi_str_mv 10.1016/j.vaccine.2006.07.036
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68374818</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X06009042</els_id><sourcerecordid>3379231371</sourcerecordid><originalsourceid>FETCH-LOGICAL-c507t-91b04f6ba426b707ad21f969464d4705e51c0716481caee0ef88f782567717593</originalsourceid><addsrcrecordid>eNqFkl-L1DAUxYso7rj6EZSC6FvrTZom7Ysii38WF3zQBd9CJr2dTW2TMUkHBvzwpk5hYF_2KST53cO599wse0mgJED4u6E8KK2NxZIC8BJECRV_lG1II6qC1qR5nG2AclYwAr8usmchDABQV6R9ml0QAQJa3myyv9fTNFu3Q2u0icdc2S43tpt1NM7mrs_N___R7YxWYz7h5PxxeY93mN_hPqqDGtHGfG9xnpx2esG0s8O8UxHz1WTSzPceI_opv_2Wbr2yMTzPnvRqDPhiPS-z28-ffl59LW6-f7m--nhT6BpELFqyBdbzrWKUb5Nz1VHSt7xlnHVMQI010SAIZw3RChGwb5peNLTmQhBRt9Vl9vaku_fuz4whyskEjeOoLLo5SN5UIhU3D4KkZYIDZQl8fQ8c3OxtakKSmgnCat7SRNUnSnsXgsde7r2ZlD9KAnJJUQ5yHZBcUpQgZEox1b1a1efthN25ao0tAW9WQIU0794rq004cw2jKfql8Q8nDtN0Dwa9DNqg1dgZjzrKzpkHrby_p6BHY5dd-I1HDOeuZaAS5I9l5ZaNAw7QAqPVP2d40vo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1547145692</pqid></control><display><type>article</type><title>Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>ProQuest Central UK/Ireland</source><creator>Ruggeberg, Jens U ; Collins, Clare ; Clarke, Paul ; Johnson, Nik ; Sinha, Ruchi ; Everest, Neil ; Chang, John ; Stanford, Elaine ; Balmer, Paul ; Borrow, Ray ; Martin, Sarah ; Robinson, Michael J ; Moxon, E Richard ; Pollard, Andrew J ; Heath, Paul T</creator><creatorcontrib>Ruggeberg, Jens U ; Collins, Clare ; Clarke, Paul ; Johnson, Nik ; Sinha, Ruchi ; Everest, Neil ; Chang, John ; Stanford, Elaine ; Balmer, Paul ; Borrow, Ray ; Martin, Sarah ; Robinson, Michael J ; Moxon, E Richard ; Pollard, Andrew J ; Heath, Paul T</creatorcontrib><description>Abstract Data on the immunogenicity and memory induction of pneumococcal conjugate vaccines in very preterm infants is limited. We vaccinated 69 full term and 68 preterm infants (median gestational age (GA) 30 weeks) with a 7-valent pneumococcal conjugate vaccine (PCV7) at 2/3/4 months of age, followed by a plain polysaccharide booster at 12 months of age. IgG-GMC (ELISA) was significantly lower in preterm infants to six vaccine serotypes (ST) at 2 months and 5 months of age, to five ST at 12 months of age and to three ST at 13 months of age. A significantly lower proportion of preterm infants achieved IgG levels ≥0.35 μg/ml to ST 4, 6B and 9V at 5 months and to ST 4, 6B, 18C, 19F and 23F at 12 months of age. Fold rises following the polysaccharide booster were comparable to those of term infants. At least 93% of both cohorts achieved IgG ≥0.35 μg/ml to all STs following booster vaccination. Pneumococcal conjugate vaccine at an accelerated schedule of 2/3/4 months of age is likely to provide protection against pneumococcal disease for preterm infants. Antibody concentrations wane over the first year of life in both preterm and term infants and booster vaccination is therefore likely to be important.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2006.07.036</identifier><identifier>PMID: 17070968</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Age ; Allergy and Immunology ; Antibodies, Bacterial - blood ; Antigens ; Applied microbiology ; Bacterial Capsules ; Bacteriology ; Biological and medical sciences ; Confidence intervals ; Female ; Fundamental and applied biological sciences. Psychology ; Haemophilus Vaccines - immunology ; Heptavalent Pneumococcal Conjugate Vaccine ; Humans ; Immunogenicity ; Immunologic Memory ; Immunological memory ; Infant ; Infant, Newborn ; Infant, Premature ; Infants ; Male ; Meningococcal Vaccines - immunology ; Microbiology ; Miscellaneous ; Pneumococcal conjugate vaccine ; Pneumococcal Vaccines - immunology ; Polysaccharides, Bacterial - immunology ; Premature birth ; Prematurity ; Streptococcus pneumoniae - immunology ; Vaccination ; Vaccines ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><ispartof>Vaccine, 2007-01, Vol.25 (2), p.264-271</ispartof><rights>Elsevier Ltd</rights><rights>2006 Elsevier Ltd</rights><rights>2007 INIST-CNRS</rights><rights>Copyright Elsevier Limited Jan 4, 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c507t-91b04f6ba426b707ad21f969464d4705e51c0716481caee0ef88f782567717593</citedby><cites>FETCH-LOGICAL-c507t-91b04f6ba426b707ad21f969464d4705e51c0716481caee0ef88f782567717593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1547145692?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974,64362,64364,64366,72216</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18422649$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17070968$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ruggeberg, Jens U</creatorcontrib><creatorcontrib>Collins, Clare</creatorcontrib><creatorcontrib>Clarke, Paul</creatorcontrib><creatorcontrib>Johnson, Nik</creatorcontrib><creatorcontrib>Sinha, Ruchi</creatorcontrib><creatorcontrib>Everest, Neil</creatorcontrib><creatorcontrib>Chang, John</creatorcontrib><creatorcontrib>Stanford, Elaine</creatorcontrib><creatorcontrib>Balmer, Paul</creatorcontrib><creatorcontrib>Borrow, Ray</creatorcontrib><creatorcontrib>Martin, Sarah</creatorcontrib><creatorcontrib>Robinson, Michael J</creatorcontrib><creatorcontrib>Moxon, E Richard</creatorcontrib><creatorcontrib>Pollard, Andrew J</creatorcontrib><creatorcontrib>Heath, Paul T</creatorcontrib><title>Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Abstract Data on the immunogenicity and memory induction of pneumococcal conjugate vaccines in very preterm infants is limited. We vaccinated 69 full term and 68 preterm infants (median gestational age (GA) 30 weeks) with a 7-valent pneumococcal conjugate vaccine (PCV7) at 2/3/4 months of age, followed by a plain polysaccharide booster at 12 months of age. IgG-GMC (ELISA) was significantly lower in preterm infants to six vaccine serotypes (ST) at 2 months and 5 months of age, to five ST at 12 months of age and to three ST at 13 months of age. A significantly lower proportion of preterm infants achieved IgG levels ≥0.35 μg/ml to ST 4, 6B and 9V at 5 months and to ST 4, 6B, 18C, 19F and 23F at 12 months of age. Fold rises following the polysaccharide booster were comparable to those of term infants. At least 93% of both cohorts achieved IgG ≥0.35 μg/ml to all STs following booster vaccination. Pneumococcal conjugate vaccine at an accelerated schedule of 2/3/4 months of age is likely to provide protection against pneumococcal disease for preterm infants. Antibody concentrations wane over the first year of life in both preterm and term infants and booster vaccination is therefore likely to be important.</description><subject>Age</subject><subject>Allergy and Immunology</subject><subject>Antibodies, Bacterial - blood</subject><subject>Antigens</subject><subject>Applied microbiology</subject><subject>Bacterial Capsules</subject><subject>Bacteriology</subject><subject>Biological and medical sciences</subject><subject>Confidence intervals</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Haemophilus Vaccines - immunology</subject><subject>Heptavalent Pneumococcal Conjugate Vaccine</subject><subject>Humans</subject><subject>Immunogenicity</subject><subject>Immunologic Memory</subject><subject>Immunological memory</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infant, Premature</subject><subject>Infants</subject><subject>Male</subject><subject>Meningococcal Vaccines - immunology</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Pneumococcal conjugate vaccine</subject><subject>Pneumococcal Vaccines - immunology</subject><subject>Polysaccharides, Bacterial - immunology</subject><subject>Premature birth</subject><subject>Prematurity</subject><subject>Streptococcus pneumoniae - immunology</subject><subject>Vaccination</subject><subject>Vaccines</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkl-L1DAUxYso7rj6EZSC6FvrTZom7Ysii38WF3zQBd9CJr2dTW2TMUkHBvzwpk5hYF_2KST53cO599wse0mgJED4u6E8KK2NxZIC8BJECRV_lG1II6qC1qR5nG2AclYwAr8usmchDABQV6R9ml0QAQJa3myyv9fTNFu3Q2u0icdc2S43tpt1NM7mrs_N___R7YxWYz7h5PxxeY93mN_hPqqDGtHGfG9xnpx2esG0s8O8UxHz1WTSzPceI_opv_2Wbr2yMTzPnvRqDPhiPS-z28-ffl59LW6-f7m--nhT6BpELFqyBdbzrWKUb5Nz1VHSt7xlnHVMQI010SAIZw3RChGwb5peNLTmQhBRt9Vl9vaku_fuz4whyskEjeOoLLo5SN5UIhU3D4KkZYIDZQl8fQ8c3OxtakKSmgnCat7SRNUnSnsXgsde7r2ZlD9KAnJJUQ5yHZBcUpQgZEox1b1a1efthN25ao0tAW9WQIU0794rq004cw2jKfql8Q8nDtN0Dwa9DNqg1dgZjzrKzpkHrby_p6BHY5dd-I1HDOeuZaAS5I9l5ZaNAw7QAqPVP2d40vo</recordid><startdate>20070104</startdate><enddate>20070104</enddate><creator>Ruggeberg, Jens U</creator><creator>Collins, Clare</creator><creator>Clarke, Paul</creator><creator>Johnson, Nik</creator><creator>Sinha, Ruchi</creator><creator>Everest, Neil</creator><creator>Chang, John</creator><creator>Stanford, Elaine</creator><creator>Balmer, Paul</creator><creator>Borrow, Ray</creator><creator>Martin, Sarah</creator><creator>Robinson, Michael J</creator><creator>Moxon, E Richard</creator><creator>Pollard, Andrew J</creator><creator>Heath, Paul T</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20070104</creationdate><title>Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants</title><author>Ruggeberg, Jens U ; Collins, Clare ; Clarke, Paul ; Johnson, Nik ; Sinha, Ruchi ; Everest, Neil ; Chang, John ; Stanford, Elaine ; Balmer, Paul ; Borrow, Ray ; Martin, Sarah ; Robinson, Michael J ; Moxon, E Richard ; Pollard, Andrew J ; Heath, Paul T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c507t-91b04f6ba426b707ad21f969464d4705e51c0716481caee0ef88f782567717593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Age</topic><topic>Allergy and Immunology</topic><topic>Antibodies, Bacterial - blood</topic><topic>Antigens</topic><topic>Applied microbiology</topic><topic>Bacterial Capsules</topic><topic>Bacteriology</topic><topic>Biological and medical sciences</topic><topic>Confidence intervals</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Haemophilus Vaccines - immunology</topic><topic>Heptavalent Pneumococcal Conjugate Vaccine</topic><topic>Humans</topic><topic>Immunogenicity</topic><topic>Immunologic Memory</topic><topic>Immunological memory</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infant, Premature</topic><topic>Infants</topic><topic>Male</topic><topic>Meningococcal Vaccines - immunology</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Pneumococcal conjugate vaccine</topic><topic>Pneumococcal Vaccines - immunology</topic><topic>Polysaccharides, Bacterial - immunology</topic><topic>Premature birth</topic><topic>Prematurity</topic><topic>Streptococcus pneumoniae - immunology</topic><topic>Vaccination</topic><topic>Vaccines</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ruggeberg, Jens U</creatorcontrib><creatorcontrib>Collins, Clare</creatorcontrib><creatorcontrib>Clarke, Paul</creatorcontrib><creatorcontrib>Johnson, Nik</creatorcontrib><creatorcontrib>Sinha, Ruchi</creatorcontrib><creatorcontrib>Everest, Neil</creatorcontrib><creatorcontrib>Chang, John</creatorcontrib><creatorcontrib>Stanford, Elaine</creatorcontrib><creatorcontrib>Balmer, Paul</creatorcontrib><creatorcontrib>Borrow, Ray</creatorcontrib><creatorcontrib>Martin, Sarah</creatorcontrib><creatorcontrib>Robinson, Michael J</creatorcontrib><creatorcontrib>Moxon, E Richard</creatorcontrib><creatorcontrib>Pollard, Andrew J</creatorcontrib><creatorcontrib>Heath, Paul T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ruggeberg, Jens U</au><au>Collins, Clare</au><au>Clarke, Paul</au><au>Johnson, Nik</au><au>Sinha, Ruchi</au><au>Everest, Neil</au><au>Chang, John</au><au>Stanford, Elaine</au><au>Balmer, Paul</au><au>Borrow, Ray</au><au>Martin, Sarah</au><au>Robinson, Michael J</au><au>Moxon, E Richard</au><au>Pollard, Andrew J</au><au>Heath, Paul T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2007-01-04</date><risdate>2007</risdate><volume>25</volume><issue>2</issue><spage>264</spage><epage>271</epage><pages>264-271</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>Abstract Data on the immunogenicity and memory induction of pneumococcal conjugate vaccines in very preterm infants is limited. We vaccinated 69 full term and 68 preterm infants (median gestational age (GA) 30 weeks) with a 7-valent pneumococcal conjugate vaccine (PCV7) at 2/3/4 months of age, followed by a plain polysaccharide booster at 12 months of age. IgG-GMC (ELISA) was significantly lower in preterm infants to six vaccine serotypes (ST) at 2 months and 5 months of age, to five ST at 12 months of age and to three ST at 13 months of age. A significantly lower proportion of preterm infants achieved IgG levels ≥0.35 μg/ml to ST 4, 6B and 9V at 5 months and to ST 4, 6B, 18C, 19F and 23F at 12 months of age. Fold rises following the polysaccharide booster were comparable to those of term infants. At least 93% of both cohorts achieved IgG ≥0.35 μg/ml to all STs following booster vaccination. Pneumococcal conjugate vaccine at an accelerated schedule of 2/3/4 months of age is likely to provide protection against pneumococcal disease for preterm infants. Antibody concentrations wane over the first year of life in both preterm and term infants and booster vaccination is therefore likely to be important.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>17070968</pmid><doi>10.1016/j.vaccine.2006.07.036</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2007-01, Vol.25 (2), p.264-271
issn 0264-410X
1873-2518
language eng
recordid cdi_proquest_miscellaneous_68374818
source MEDLINE; Elsevier ScienceDirect Journals; ProQuest Central UK/Ireland
subjects Age
Allergy and Immunology
Antibodies, Bacterial - blood
Antigens
Applied microbiology
Bacterial Capsules
Bacteriology
Biological and medical sciences
Confidence intervals
Female
Fundamental and applied biological sciences. Psychology
Haemophilus Vaccines - immunology
Heptavalent Pneumococcal Conjugate Vaccine
Humans
Immunogenicity
Immunologic Memory
Immunological memory
Infant
Infant, Newborn
Infant, Premature
Infants
Male
Meningococcal Vaccines - immunology
Microbiology
Miscellaneous
Pneumococcal conjugate vaccine
Pneumococcal Vaccines - immunology
Polysaccharides, Bacterial - immunology
Premature birth
Prematurity
Streptococcus pneumoniae - immunology
Vaccination
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
title Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T12%3A04%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunogenicity%20and%20induction%20of%20immunological%20memory%20of%20the%20heptavalent%20pneumococcal%20conjugate%20vaccine%20in%20preterm%20UK%20infants&rft.jtitle=Vaccine&rft.au=Ruggeberg,%20Jens%20U&rft.date=2007-01-04&rft.volume=25&rft.issue=2&rft.spage=264&rft.epage=271&rft.pages=264-271&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/j.vaccine.2006.07.036&rft_dat=%3Cproquest_cross%3E3379231371%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1547145692&rft_id=info:pmid/17070968&rft_els_id=S0264410X06009042&rfr_iscdi=true